Clinical Trial Update: Frontline Lenalidomide for AL Amyloidosis Involving Myocardium [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating frontline lenalidomide for amyloidosis involving the heart has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Amyloidosis Cardiac | Phase 3 | Status: COMPLETED